S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
New CBOE “special perk” helps traders target income every weekend (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
Lacking counselors, US schools turn to the booming business of online therapy
New CBOE “special perk” helps traders target income every weekend (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal with debt
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
New CBOE “special perk” helps traders target income every weekend (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
Lacking counselors, US schools turn to the booming business of online therapy
New CBOE “special perk” helps traders target income every weekend (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal with debt
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
New CBOE “special perk” helps traders target income every weekend (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
Lacking counselors, US schools turn to the booming business of online therapy
New CBOE “special perk” helps traders target income every weekend (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal with debt
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
New CBOE “special perk” helps traders target income every weekend (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
Lacking counselors, US schools turn to the booming business of online therapy
New CBOE “special perk” helps traders target income every weekend (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal with debt
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt

OptimizeRx Stock Price, News & Analysis (NASDAQ:OPRX)

$9.96
+0.45 (+4.73%)
(As of 12/1/2023 ET)
Compare
Today's Range
$9.46
$10.03
50-Day Range
$7.06
$10.02
52-Week Range
$6.92
$20.55
Volume
235,431 shs
Average Volume
170,592 shs
Market Capitalization
$180.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.60

OptimizeRx MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
56.6% Upside
$15.60 Price Target
Short Interest
Bearish
5.08% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.65) to ($0.50) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.97 out of 5 stars

Computer And Technology Sector

384th out of 592 stocks

Business Services, Not Elsewhere Classified Industry

64th out of 86 stocks


OPRX stock logo

About OptimizeRx Stock (NASDAQ:OPRX)

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers (HCPs), and patients. Its products and applications include Evidence-Based Physician Engagement solution to assist HCPs in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations; and Point of Care Banner messaging solution to deliver a variety of awareness and messaging within the clinical workflow. The company also offers Social Network Banner Messaging solution to deliver banner messaging to HCPs within their social network apps; Institutional Account-based Banner Messaging solution that provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts; and Financial Messaging solution, which provides prescribers visibility to branded copay offers and other patient support programs directly within their electronic health record and/or e-Prescribe systems. In addition, it provides Patient Engagement, a technology solution that provides digital messaging services through its cloud-based Mobile Health Messenger platform; HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance; and Therapy Initiation Workflow, a group of digital solutions that focuses on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was founded in 2006 and is headquartered in Rochester, Michigan.

OPRX Stock Price History

OPRX Stock News Headlines

Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
OptimizeRx Corp OPRX
RBC Capital Keeps Their Buy Rating on OptimizeRx (OPRX)
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
OptimizeRx Reports Third Quarter 2023 Financial Results
A Preview Of OptimizeRx's Earnings
OptimizeRx Q3 2023 Earnings Preview
OptimizeRx (OPRX) Receives a Buy from Lake Street
OptimizeRx to acquire Medicx Health for $95M
OptimizeRx Expands AI Powered Omnichannel Platform
See More Headlines
Receive OPRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OptimizeRx and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/06/2023
Today
12/03/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/13/2024

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:OPRX
Employees
109
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$15.60
High Stock Price Target
$20.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+56.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

Net Income
$-11,440,000.00
Pretax Margin
-21.88%

Debt

Sales & Book Value

Annual Sales
$62.45 million
Book Value
$6.40 per share

Miscellaneous

Free Float
17,353,000
Market Cap
$180.77 million
Optionable
Not Optionable
Beta
1.05
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. William J. FebboMr. William J. Febbo (Age 54)
    CEO & Director
    Comp: $694.4k
  • Mr. Edward Stelmakh C.M.A. (Age 57)
    M.B.A., CFO & COO
    Comp: $547.05k
  • Mr. Andrew Jacob D'Silva
    Senior Vice President of Corporate Finance
  • Mr. Todd Inman (Age 67)
    Chief Technology Officer
  • Ms. Marion K Odence-Ford (Age 58)
    General Counsel & Chief Compliance Officer
    Comp: $428.12k
  • Maira Alejandra
    Media Relations Manager
  • Ms. Sheryl Kearney
    Human Resources Manager
  • Mr. Terence J. Hamilton (Age 58)
    Senior Vice President of Pharma
    Comp: $441.63k
  • Dr. Doug Besch (Age 41)
    Chief Product Officer
  • Ms. Theresa Greco
    Chief Commercial Officer














OPRX Stock Analysis - Frequently Asked Questions

Should I buy or sell OptimizeRx stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OptimizeRx in the last year. There are currently 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" OPRX shares.
View OPRX analyst ratings
or view top-rated stocks.

What is OptimizeRx's stock price target for 2024?

8 Wall Street research analysts have issued 1-year price targets for OptimizeRx's stock. Their OPRX share price targets range from $13.00 to $20.00. On average, they predict the company's share price to reach $15.60 in the next twelve months. This suggests a possible upside of 56.6% from the stock's current price.
View analysts price targets for OPRX
or view top-rated stocks among Wall Street analysts.

How have OPRX shares performed in 2023?

OptimizeRx's stock was trading at $16.80 at the beginning of 2023. Since then, OPRX stock has decreased by 40.7% and is now trading at $9.96.
View the best growth stocks for 2023 here
.

When is OptimizeRx's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 13th 2024.
View our OPRX earnings forecast
.

How were OptimizeRx's earnings last quarter?

OptimizeRx Co. (NASDAQ:OPRX) posted its earnings results on Monday, November, 6th. The company reported ($0.10) EPS for the quarter, beating analysts' consensus estimates of ($0.19) by $0.09. The company had revenue of $16.33 million for the quarter, compared to analysts' expectations of $15.07 million. OptimizeRx had a negative trailing twelve-month return on equity of 9.24% and a negative net margin of 21.88%.

What ETFs hold OptimizeRx's stock?

ETFs with the largest weight of OptimizeRx (NASDAQ:OPRX) stock in their portfolio include Jacob Forward ETF (JFWD).Global X Telemedicine & Digital Health ETF (EDOC).

What guidance has OptimizeRx issued on next quarter's earnings?

OptimizeRx updated its FY 2023 earnings guidance on Monday, November, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $63.00 million-$65.00 million, compared to the consensus revenue estimate of $60.51 million.

What other stocks do shareholders of OptimizeRx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OptimizeRx investors own include InterDigital (IDCC), Bank of Hawaii (BOH), NVIDIA (NVDA), STAG Industrial (STAG), Etsy (ETSY), Marvell Technology (MRVL), Trade Desk (TTD), Verizon Communications (VZ), Advanced Micro Devices (AMD) and Amgen (AMGN).

Who are OptimizeRx's major shareholders?

OptimizeRx's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Blair William & Co. IL (5.03%), AWM Investment Company Inc. (4.70%), Kennedy Capital Management LLC (3.34%), Rice Hall James & Associates LLC (2.33%), Jacob Asset Management of New York LLC (2.23%) and Federated Hermes Inc. (2.09%). Insiders that own company stock include Douglas P Baker, Douglas P Baker, Edward Stelmakh, Ellen O'connor Vos, James Paul Lang, Marion Odence-Ford, Miriam J Paramore, Patrick D Spangler, Stephen L Silvestro, Stephen L Silvestro and William J Febbo.
View institutional ownership trends
.

How do I buy shares of OptimizeRx?

Shares of OPRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:OPRX) was last updated on 12/3/2023 by MarketBeat.com Staff

My Account -